NEA Management Company’s Addex Therapeutics ADXN Stock Holding History

NEA Management Company’s Portfolio ADXN Stock Details ADXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,000	Closed	-$306K	–	46
2023 Q4	$306K	Hold	9,000	–	–	0.02%	44
2023 Q3	$408K	Hold	9,000	–	–	0.03%	43
2023 Q2	$633K	Sell	9,000 -273,435	-97%	-$3.97M	0.05%	42
2023 Q1	$1.11M	Buy	282,435 +228,435	+423%	+$5.77M	0.08%	43
2022 Q4	$113K	Sell	54,000 -228,435	-81%	-$3.37M	0.01%	54
2022 Q3	$830K	Buy	282,435 +235,363	+500%	+$5.27M	0.04%	53
2022 Q2	$1.08M	Buy	47,072 +38,072	+423%	+$2.86M	0.06%	54
2022 Q1	$914K	Hold	9,000	–	–	0.03%	55
2021 Q4	$205K	Hold	9,000	–	–	﹤0.01%	58
2021 Q3	$1.62M	Hold	9,000	–	–	0.02%	60
2021 Q2	$17.2M	Buy	+9,000	New	+$1.83M	0.22%	46

Other funds holding ADXN

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

NEA Management Company's ADXN Position: Q1 2024 in Review

NEA Management Company sold out of Addex Therapeutics (ADXN) in Q1 2024, closing a stake of 9,000 shares — an estimated $306K sold.

NEA Management Company first reported a position in ADXN in Q2 2021 and held it in 11 quarters. The position peaked at $17.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds ADXN as of Q1 2024.

NEA Management Company reported no remaining Addex Therapeutics position as of Q1 2024 after selling out during the quarter.
NEA Management Company sold 9,000 Addex Therapeutics shares in Q1 2024, an estimated $306K.
NEA Management Company first reported a position in Addex Therapeutics in Q2 2021 and held it in 11 quarters.
NEA Management Company's Addex Therapeutics position peaked at $17.2M in Q2 2021.
1 fund tracked by Wall St. Rank held Addex Therapeutics as of Q1 2024.

Based on NEA Management Company's 13F filing for Q1 2024, filed 15 May 2024.